BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8607364)

  • 1. Interferon therapy in an infant with Kasabach-Merritt syndrome.
    Yeh KW; Jiang TH; Hung IJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):368-72. PubMed ID: 8607364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome.
    Nako Y; Fukushima N; Igarashi T; Hoshino M; Sugiyama M; Tomomasa T; Morikawa A
    J Perinatol; 1997; 17(3):244-7. PubMed ID: 9210084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant alpha-interferon treatment of intracranial hemangioma and Kasabach-Merritt syndrome in an infant with cytomegalovirus.
    Chiu HH; Chen RL; Lin KH; Lin DT; Lin KS
    J Formos Med Assoc; 1995 May; 94(5):261-6. PubMed ID: 7613260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha.
    Hesselmann S; Micke O; Marquardt T; Baas S; Bramswig JH; Harms E; Willich N
    Br J Radiol; 2002 Feb; 75(890):180-4. PubMed ID: 11893644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset].
    González de Dios J; Moya Benavent M; Herranz Sánchez Y; Juste Ruiz M; González Montero R
    An Esp Pediatr; 1996 Feb; 44(2):179-83. PubMed ID: 8830584
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Kasabach Merritt syndrome].
    Lanau Arilla MP; García Erce JA; Torres Gómez M; Lucía Cuesta JF; Giralt Raichs M
    Sangre (Barc); 1998 Jun; 43(3):218-22. PubMed ID: 9741229
    [No Abstract]   [Full Text] [Related]  

  • 7. Brachial plexus paralysis due to giant cavernous hemangioma with Kasabach-Merritt syndrome: successful management with interferon alpha.
    Peker E; Kirimi E; Tuncer O; Ceylan A; Oner AF
    Platelets; 2009 Dec; 20(8):603-5. PubMed ID: 19929246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute ethanol embolotherapy for hemangioma with Kasabach-Merritt syndrome.
    Yang YH; Lee PI; Lin KH; Tsang YM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(1):51-4. PubMed ID: 9553294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon.
    Deb G; Jenkner A; De Sio L; Boldrini R; Bosman C; Standoli N; Donfrancesco A
    Med Pediatr Oncol; 1997 May; 28(5):358-61. PubMed ID: 9121401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review.
    Frevel T; Rabe H; Uckert F; Harms E
    Eur J Pediatr; 2002 May; 161(5):243-6. PubMed ID: 12012216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline.
    de la Hunt MN
    J Pediatr Surg; 2006 Jan; 41(1):e29-31. PubMed ID: 16410085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is alfa-interferon still current in the management of Kasabach-Merritt syndrome?].
    Duclaux-Loras R; Lachaux A; Guibaud L; Bertrand Y
    Arch Pediatr; 2015 May; 22(5):523-7. PubMed ID: 25858451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon.
    Wananukul S; Nuchprayoon I; Seksarn P
    Int J Dermatol; 2003 Sep; 42(9):741-8. PubMed ID: 12956695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon.
    Ettlinger JJ; Fleming PJ; Joffe HS; Kennedy CT
    J R Soc Med; 1996 Jan; 89(1):55P-6P. PubMed ID: 8709089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious childhood angiomas: unsuccessful alpha-2b interferon treatment. A report of four cases.
    Teillac-Hamel D; De Prost Y; Bodemer C; Andry P; Enjolras O; Sebag G; Brunelle F; Hubert P; Nihoul-Fekete C
    Br J Dermatol; 1993 Oct; 129(4):473-6. PubMed ID: 8217766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of interferon alfa-2a for life-threatening hemangiomas.
    MacArthur CJ; Senders CW; Katz J
    Arch Otolaryngol Head Neck Surg; 1995 Jun; 121(6):690-3. PubMed ID: 7772325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kasabach-Merrit syndrome in infants.
    Sarihan H; Mocan H; Abeys M; Akyazici R; Cay A; Imamoğlu M
    Panminerva Med; 1998 Jun; 40(2):128-31. PubMed ID: 9689834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region.
    Su L; Wang D; Fan X
    J Oral Maxillofac Surg; 2015 Jan; 73(1):92-8. PubMed ID: 25511959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful transcutaneous arterial embolization of a giant hemangioma associated with high-output cardiac failure and Kasabach-Merritt syndrome in a neonate: a case report.
    Hosono S; Ohno T; Kimoto H; Nagoshi R; Shimizu M; Nozawa M; Fuyama Y; Kaneda T; Moritani T; Aihara T
    J Perinat Med; 1999; 27(5):399-403. PubMed ID: 10642962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcerated haemangioma successfully treated with interferon alfa-2b and topical granulocyte-macrophage colony-stimulating factor.
    Illum N; Karlsmark T; Svejgaard E; Ullman S; Yssing M
    Dermatology; 1995; 191(4):315-7. PubMed ID: 8573929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.